Drugmakers oppose new drug-pricing plan

Pharmaceutical companies are vehemently opposing to the government’s plan to provide doctors with incentives in terms of pricing, which was made public on February 16.

The Korea Pharmaceutical Manufacturers Association said in a press release that inducing hospitals and doctors to give out discounts will only fuel severe price competition among drug makers, adding the illegal rebate practice...